Facial Injectables Market Size & Forecast Report, 2014 - 2025

Global Facial Injectables Market is expected to reach USD 17.2 billion by 2025. Facial injectable is also termed as facial filler, or facial injections, or injectable fillers are the products like calcium hydroxylapatite, collagen, and hyaluronic acid that revitalize facial skin by reducing and eradicating wrinkles, enhancing lips, raising scar depressions, and altering soft-tissue volume loss through facial injections. Probably the results are temporary that lasts from few months to years. The Facial Injectable Market is estimated to grow at a significant CAGR of 11.5% over the forecast period as the scope and its applications are rising enormously across the globe.

Growing demand from middle age populace, growing urbanization, and increasing esthetic standards are documented as major factors of Facial Injectables Market that are estimated to enhance the growth in the years to come. However, its side effects and high cost may restrain overall market growth in the coming years. Facial Injectables industry is segmented based on product type, end user, and region.

Anti-aging/ Anti-wrinkle Injections and Dermal Fillers/Injectable Implants are the product types that could be explored in Facial Injectables in the forecast period. Anti-aging/ Anti-wrinkle Injections comprise Synthetic Fillers, Hyaluronic Acid, and Collagen Fillers. Synthetic fillers include polymethyl methacrylate microspheres, Calcium hydroxyapatite, and others. Anti-aging/ Anti-wrinkle Injections comprises Poly-L-lactic acid (PLLA) micro particles and Botulinum toxin A. The market may be categorized based on end users like Dermatology Research Institutes, Hospitals, Beauty Clinics, Dermatology Clinics, and others that could be explored in the forecast period.

There various applications like therapeutics, aesthetics, and others that could be explored in Facial Injectables in the forecast period. The aesthetics sector accounted for the substantial market share and is estimated to continue its dominance in the coming years. This may be because of rising use in procedures like wrinkles, acne scars, parentheses lines, lip border restoration, crow’s feet lines, periorbital wrinkles, marionette lines and others. Also, therapeutic sector is estimated to grow at highest CAGR in the coming years.

Globally, North America accounted for the substantial market share of Facial Injectables and is estimated to lead the overall market in the coming years. The reason behind the overall market share could be rising spending on aesthetic procedures and presence of geriatric population base in Canada and the U.S.

Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The aspects that may be ascribed to the growth comprise growing acceptance of combination treatments and growing number of medical tourists in Brazil. The developing countries like India and China are the major consumers of Facial Injectable in the region.

The key players of Facial Injectables Market are Galderma S.A., ALLERGAN, Prollenium Medical Technologies Inc., Ipsen, Anika Therapeutics, Inc., Merz Pharma, Bloomage Bio Technology Corporation Limited, Suneva Medical, Inc., Sinclair Pharma, and Medytox, Inc. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As companies all over the world have to believe that alliance with a market would permit them proportional market existence and authority to declare the leadership position.

Market Segment:

Facial Injectables Product Outlook (Revenue, USD Million, 2014 - 2025)
    • Collagen
    • Hyaluronic Acid (HA)
    • Botulinum Toxin Type A
    • Calcium Hydroxylapatite (CaHA)
    • Polymer Fillers
        • Polymethylmethacrylate Beads (PMMA Microspheres)
        • Poly-L-lactic acid (PLLA)

Facial Injectables Application Outlook (Revenue, USD Million, 2014 - 2025)
    • Aesthetics
    • Therapeutics

Facial Injectables Regional Outlook (Revenue, USD Million, 2014 - 2025)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • UK
    • Asia Pacific
        • Japan
        • China
        • India
    • Latin America
        • Brazil
        • Mexico
    • Middle East and Africa (MEA)
        • South Africa